SK Biopharmaceuticals Revenue

In the year 2024, SK Biopharmaceuticals had annual revenue of 547.60B KRW with 54.30% growth. SK Biopharmaceuticals had revenue of 163.02B in the quarter ending December 31, 2024, with 28.61% growth.

Revenue

547.60B

Revenue Growth

+54.30%

P/S Ratio

12.93

Revenue / Employee

2.27B

Employees

241

Market Cap

7,079.52B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	547.60B	192.70B	54.30%
Dec 31, 2023	354.89B	108.71B	44.16%
Dec 31, 2022	246.18B	-172.47B	-41.20%
Dec 31, 2021	418.64B	392.65B	1,510.23%
Dec 31, 2020	26.00B	-97.85B	-79.01%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
ALTEOGEN	102.85B
Yuhan	2,067.79B
HLB Co., Ltd.	68.13B
PharmaResearch	350.12B
Peptron	3.15B
LigaChem Biosciences	125.90B

Revenue Rankings